Skip to content
Research Article Open access CC BY 4.0

Neurological Complications of COVID-19 Vaccination: A Case Report of Generalized Convulsive Status Epilepticus

Machlusil Husna, Ria Damayanti, Priyo Atdisuramad

International Journal of Medical and Pharmaceutical Case Reports · pp. 80–86 · Published 7 Dec 2023

10.9734/ijmpcr/2023/v16i4355

Abstract

Generalized convulsive status epilepticus (GCSE) is a life-threatening condition characterized by prolonged seizure activity that affects both sides of the brain. Despite its high mortality rate, GCSE is a relatively rare complication of COVID-19 vaccination. In this case report, we presented a 28-year-old male with no known history of neuropsychiatric disorders who developed GCSE following the first dose of the mRNA COVID-19 vaccine. It is plausible that the COVID-19 vaccine played a role in the development of GCSE in this patient. This case report also provides brief review potential association between COVID-19 vaccination and GCSE. Enhanced post-vaccination monitoring protocols are essential for ensuring the safety of COVID-19 vaccination for patients with underlying medical conditions or those at heightened risk of neurological complications.

Generalized Convulsive Status Epilepticus (GCSE) mRNA COVID-19 vaccine COVID-19 vaccination

References (18)

  1. 1 A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus [DOI]
  2. 2 Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial [DOI]
  3. 3 Systematic review of EEG findings in 617 patients diagnosed with COVID-19 [DOI]
  4. 4 Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? [DOI]
  5. 5 COVID-19 Infection and Neurological Complications: Present Findings and Future Predictions [DOI]
  6. 6 Epidemiology of status epilepticus in adults: Apples, pears, and oranges — A critical review [DOI]
  7. 7 Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study [DOI]
  8. 8 COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center [DOI]
  9. 9 Characterisation of the pro-inflammatory cytokine signature in severe COVID-19 [DOI]
  10. 10 Treatment of Convulsive Status Epilepticus [DOI]
  11. 11 From early limbic inflammation to long COVID sequelae [DOI]
  12. 12 Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health-care system experience [DOI]
  13. 13 Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination [DOI]
  14. 14 Neuropsychiatric Disorders and COVID-19: What We Know So Far [DOI]
  15. 15 Post COVID-19 vaccine deaths - Singapore’s early experience [DOI]
  16. 16 Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study [DOI]
  17. 17 Electroencephalographic findings post‐COVID‐19 vaccination: A systematic review of case reports and case series [DOI]
  18. 18 STUDY PROTOCOL Established Status Epilepticus Treatment Trial (ESETT)

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

4

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.